K 2021–2519 Annual report 2020 Introduction ........................................................................................................................................ 4 COVID-19 ............................................................................................................................................ 4 Vision and long-term strategies ......................................................................................................... 5 Organisation ....................................................................................................................................... 5 Karolinska Comprehensive Cancer Center ..................................................................................... 5 Board of Directors .......................................................................................................................... 6 The Cancer Theme .......................................................................................................................... 7 Management structure of the Cancer Theme ................................................................................ 7 Cancer Research KI ......................................................................................................................... 7 National and international networks ................................................................................................. 8 Care ................................................................................................................................................ 8 Education ........................................................................................................................................ 8 Research ......................................................................................................................................... 9 Key events during the year ................................................................................................................. 9 Care production and accessibility .................................................................................................... 10 Outcome data for the Cancer Theme’s activities 2018–2020 ...................................................... 11 First visit ....................................................................................................................................... 11 Standardized care pathway .......................................................................................................... 11 Surgeries ....................................................................................................................................... 13 Human Resources ............................................................................................................................. 13 Employees .................................................................................................................................... 13 Mentorship program ................................................................................................................ 14 Quality report ................................................................................................................................... 14 Quality management system ....................................................................................................... 14 Quality follow-up .......................................................................................................................... 14 Personalized care, follow-up of the experience of received care ................................................ 15 Patient satisfaction ................................................................................................................... 15 Nursing – Nutrition, pressure ulcers and falls .............................................................................. 15 Nutrition ................................................................................................................................... 15 Pressure ulcers ......................................................................................................................... 16 Fall ............................................................................................................................................ 16 Healthcare related infections and hygiene .................................................................................. 16 Healthcare related infections ................................................................................................... 16 Basic hygiene and clothing rules .............................................................................................. 17 Multiresistant bacteria ............................................................................................................. 17 1 Patient safety................................................................................................................................ 18 Environment ................................................................................................................................. 18 Business development ..................................................................................................................... 19 Green Cross .................................................................................................................................. 19 The work of the multidisciplinary team ....................................................................................... 20 Patient involvement ..................................................................................................................... 20 Palliative care ............................................................................................................................... 20 Contact nurses .............................................................................................................................. 20 My Care Plan ................................................................................................................................ 21 Cancer rehabilitation .................................................................................................................... 21 My Code ....................................................................................................................................... 21 Research, education and development............................................................................................ 22 Scientific Advisory Board .............................................................................................................. 22 Science for Life Laboratory ........................................................................................................... 22 Scientific production and technology development ................................................................ 23 Data driven Life Science initiative ............................................................................................ 23 Health Care ............................................................................................................................... 23 Test beds and tools for validating and implementing new technologies ................................ 23 Preclinical and translational research .......................................................................................... 24 Cancer papers from KI 2020 ..................................................................................................... 26 Caring sciences ......................................................................................................................... 27 Department of Breast cancer, Endocrine tumours and Sarcoma ............................................ 28 Breast cancer ........................................................................................................................ 28 Endocrine tumours ............................................................................................................... 29 Sarcomas .............................................................................................................................. 29 Department of Cell therapy and Allogeneic stem cell transplant ............................................ 29 Department of Haematology ................................................................................................... 30 Myeloma ............................................................................................................................... 30 Myeloid malignancies ........................................................................................................... 30 Lymphoma ............................................................................................................................ 30 Department of Head, Neck, Lung and Skin cancer ................................................................... 30 Head and neck cancer .......................................................................................................... 30 Lung cancer........................................................................................................................... 31 Melanoma ............................................................................................................................ 32 Department of Pelvic cancer ...................................................................................................